This article shows that portfolios that aim to diversify across countries and across industries
provide markedly better reward-to-risk ratios than the traditional asset allocation strategies …

Trabecular bone loss in estrogen deficiency is associated with enhanced bone resorption
with a smaller increase in bone formation. We previously reported that low doses of strontium …

… It has been demonstrated that postmenopausal women treated daily with 2 g of S 12911–2
and with similar plasma strontium concentrations had a 41% reduction in relative risk of …

The absorbed dose at CT was measured at nine points in a 16 cm diameter phantom. The
effect of different reconstruction algorithms and scan settings on the quality of head CT images …

… Bone Sr content values obtained in the present study (Table 1) are lower than those (40-60
mg/g depending on the dose) reported in rats treated with another Sr salt.(") In untreated …

The distribution and incorporation of strontium into bone has been examined in rats, monkeys,
and humans after oral administration of strontium (either strontium chloride or strontium …

… progressively decreasing density (at 0.1 g/mL steps) was collected. … g/mL, the precipitate
obtained from the initial 2.0 g/mL density solution was resuspended in a solution of density 2.3 g/…

An operational definition of musculoskeletal decline in older people is needed to allow
development of interventions for prevention or treatment, as was developed for the treatment of …

… ( 15,42 ) In a prevention 2‐year study, 1 g/day of strontium ranelate given to early postmenopausal
women without prevalent osteoporosis, induced a significant increase in spine bone …

Strontium ranelate (S12911) has previously been shown to stimulate bone formation and
inhibit bone resorption in rats. To determine whether strontium ranelate affects normal bone …